brimonidine tartrate has been researched along with Diabetic Retinopathy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldington, SJ; Bandello, F; Costa, MÂ; Cunha-Vaz, J; Egan, C; Frydkjaer-Olsen, U; García-Arumí, J; Gibson, J; Grauslund, J; Harding, SP; Hernández, C; Lang, GE; Lattanzio, R; Lobo, C; Massin, P; Midena, E; Ponsati, B; Porta, M; Ribeiro, L; Scanlon, P; Simó, R | 1 |
| Cunha-Vaz, J; Fernández-Carneado, J; Frydkjaer-Olsen, U; Grauslund, J; Hernández, C; Peto, T; Ponsati, B; Simó, R | 1 |
| Baser, EF; Gülhan, C; Öztürk, B; Seymenoğlu, G | 1 |
| Gupta, PC; Ichhpujani, P; Narang, S; Sood, S | 1 |
| Cunha-Vaz, J; Frydkjaer-Olsen, U; Grauslund, J; Peto, T; Simó, R; Soegaard Hansen, R | 1 |
| Arroba, AI; Beltramo, E; Hernández, C; Lopatina, T; Mazzeo, A; Porta, M; Simó, R; Valverde, AM | 1 |
| Bakri, SJ; Beer, PM | 1 |
| Baidya, KP; Bhaduri, G; Bhattacharya, B; Chatterjee, PR; Mondal, LK | 1 |
6 trial(s) available for brimonidine tartrate and Diabetic Retinopathy
| Article | Year |
|---|---|
Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.
Topics: Administration, Topical; Aged; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Middle Aged; Neuroprotective Agents; Somatostatin | 2019 |
Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Retinal Vessels; Somatostatin | 2019 |
Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Diabetic Retinopathy; Drug Combinations; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
Role of brimonidine in the treatment of clinically significant macular edema with ischemic changes in diabetic maculopathy.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Diabetic Retinopathy; Female; Humans; Ischemia; Macular Edema; Male; Middle Aged; Prospective Studies; Quinoxalines; Retinal Vessels; Visual Acuity | 2014 |
Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Therapy, Combination; Electroretinography; Female; Follow-Up Studies; Hormones; Humans; Jupiter; Male; Middle Aged; Neuroprotective Agents; Ophthalmic Solutions; Prospective Studies; Retinal Degeneration; Retinal Ganglion Cells; Retinal Vessels; Somatostatin; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2016 |
The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus.
Topics: Aneurysm; Antihypertensive Agents; Blood Glucose; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Ischemia; Middle Aged; Prospective Studies; Quinoxalines; Time Factors; Treatment Outcome; Vision, Ocular | 2004 |
2 other study(ies) available for brimonidine tartrate and Diabetic Retinopathy
| Article | Year |
|---|---|
Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Humans; Male; Microvessels; Neuroprotective Agents; Pericytes; Rats; Receptors, Somatostatin; Retina; Retinal Neurons; Somatostatin; Vascular Endothelial Growth Factor A | 2016 |
Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Quinoxalines; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |